These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20582603)

  • 1. Endotoxin elimination in sepsis: physiology and therapeutic application.
    Buttenschoen K; Radermacher P; Bracht H
    Langenbecks Arch Surg; 2010 Aug; 395(6):597-605. PubMed ID: 20582603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early endotoxin tolerance--a preventive concept against infection].
    Staubach KH; Jonas S; Kooistra A; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():360-3. PubMed ID: 9101876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
    Shoji H; Opal SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 5. Gram-negative bacteraemia: new therapeutic possibilities with anti-endotoxin antibodies.
    Gaffin SL
    Haematol Blood Transfus; 1985; 29():107-11. PubMed ID: 3896966
    [No Abstract]   [Full Text] [Related]  

  • 6. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide-Induced Toxic Shock Syndrome in Rabbits.
    Stach CS; Schlievert PM
    Methods Mol Biol; 2016; 1396():67-71. PubMed ID: 26676037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell dynamics during experimental endotoxemia in humans.
    Brinkhoff A; Zeng Y; Sieberichs A; Dolff S; Shilei X; Sun M; Engler H; Benson S; Korth J; Schedlowski M; Kribben A; Witzke O; Wilde B
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of in vivo endotoxin tolerance in horses.
    Holcombe SJ; Jacobs CC; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
    Vet Immunol Immunopathol; 2016 May; 173():10-6. PubMed ID: 27090620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis.
    Bannerman DD; Goldblum SE
    Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L899-914. PubMed ID: 12736186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis.
    Opal SM
    Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How relevant are in vivo and in vitro studies for clinical sepsis? A mathematical model of LPS signaling based on endotoxin tolerance.
    Vasilescu C; Olteanu M; Flondor P
    Chirurgia (Bucur); 2009; 104(2):195-201. PubMed ID: 19499663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous HMGB1 is required in endotoxin tolerance.
    Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
    J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies in nonantibiotic treatment of gram-negative sepsis.
    Cohn J; Bone RC
    Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin removal: history of a mission.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():5-8. PubMed ID: 24457488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxins and other sepsis triggers.
    Opal SM
    Contrib Nephrol; 2010; 167():14-24. PubMed ID: 20519895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.